Liquid-crystalline medium and liquid-crystal display comprising the same

US10190048B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10190048-B2
Application numberUS-201515502725-A
CountryUS
Kind codeB2
Filing dateJul 13, 2015
Priority dateAug 8, 2014
Publication dateJan 29, 2019
Grant dateJan 29, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a liquid-crystalline medium, preferably having a nematic phase and negative dielectric anisotropy, which comprises a) one or more compounds of formula I and b) one or more compounds selected from the group of compounds of the formulae II and III in which the parameters have the respective meanings indicated in claim 1 , to the use thereof in an electro-optical display, particularly in an active-matrix display based on the VA, ECB, PALC, IPS or FFS effect, to displays of this type which contain a liquid-crystalline medium of this type, and to the use of the compounds of formula I for reduction of the dispersion of the birefringence of a liquid-crystalline medium which comprises one or more compounds of the formulae II and/or III.

First claim

Opening claim text (preview).

The invention claimed is: 1. A liquid-crystalline medium comprising a) one or more compounds selected from the group of compounds of formulae I-1 and I-2 in which R 11 and R 12 independently of each other denote H or alkyl with 1 to 5 C atoms, and b) one or more compounds selected from the group of compounds of formulae II and III in which R 21 denotes an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkenyl radical having 2 to 7 C atoms or an unsubstituted alkoxy radical having 1 to 6 C atoms, R 22 denotes an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkoxy radical having 1 to 6 C atoms or an unsubstituted alkenyloxy radical having 2 to 6 C atoms, and l denotes 0 or 1, R 31 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkenyl radical having 2 to 7 C atoms, R 32 denotes an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkoxy radical having 1 to 6 C atoms or an unsubstituted alkenyloxy radical having 2 to 6 C atoms, and denotes 2. The medium according to claim 1 , which comprises a compound of formula I-1. 3. The medium according to claim 1 , which further comprises one or more compounds of formula IV in which R 41 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkenyl radical having 2 to 7 C atoms, and R 42 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkoxy radical having 1 to 6 C atoms. 4. The liquid-crystalline medium according to claim 1 , which further comprises one or more compounds of formula V in which R 51 and R 52 , independently of one another, denote an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkenyl radical having 2 to 7 C atoms, an unsubstituted alkoxy radical having 1 to 6 C atoms, or an unsubstituted alkenyloxy radical having 2 to 6 C atoms, if present, each, independently of one another, denote Z 51 to Z 53 each, independently of one another, denote —CH 2 —CH 2 —, —CH 2 —O—, —CH═CH—, —C≡C—, —COO— or a single bond, and i and j each, independently of one another, denote 0 or 1. 5. The liquid-crystalline medium according to claim 1 , wherein the one or more compounds of formula II and/or III are selected from the group of the compounds of formulae II-1, II-2, III-1 and III-2 in which R 21 , R 22 , R 31 , and R 32 as defined as for the compounds of formulae II and III. 6. The liquid-crystalline medium according to claim 5 , in which comprises one or more compounds of formula II selected from the group of the compounds of formulae II-1 and II-2 in which R 21 and R 22 are defined as for the compounds of formula II. 7. The medium according to claim 1 , in which the total concentration of the compounds of formulae I-1 and I-2 in the medium as a whole is 5% or more to 35% or less. 8. The medium according to claim 1 , in which the total concentration of the compounds of formula II in the medium as a whole is 25% or more to 45% or less. 9. The medium according to claim 1 , which additionally comprises one or more chiral compounds. 10. An electro-optical display or electro-optical component, which comprises a liquid-crystalline medium according to claim 1 . 11. A display according to claim 10 , which is based on the VA-, ECB-IPS- or FFS mode. 12. The display according to claim 10 , which contains an active-matrix addressing device. 13. A display according to claim 10 , which is a mobile display. 14. A process for the preparation of a liquid-crystalline medium according to claim 1 , comprising mixing together one or more compounds of formulae I-1 and I-2 with one or more compounds of formula II and/or III. 15. The medium according to claim 1 , which comprises a compound of formula I-2. 16. The medium according to claim 1 , which comprises at least one compound of each of the compounds of formulae I-1 and I-2. 17. The medium according to claim 1 , which comprises at least one compound of each of the compounds of formulae II and III. 18. The medium according to claim 1 , which further comprises one or more compounds of formula IV in which R 41 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkenyl radical having 2 to 7 C atoms, and R 42 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkoxy radical having 1 to 6 C atoms, and one or more compounds of formula V in which R 51 and R 52 , independently of one another, denote an unsubstituted alkyl radical having 1 to 7 C atoms, an unsubstituted alkenyl radical having 2 to 7 C atoms, an unsubstituted alkoxy radical having 1 to 6 C atoms, or an unsubstituted alkenyloxy radical having 2 to 6 C atoms, if present, each, independently of one another, denote Z 51 to Z 53 each, independently of one another, denote —CH 2 —CH 2 —, —CH 2 —O—, —CH═CH—, —C≡C—, —COO— or a single bond, and i and j each, independently of one another, denote 0 or 1. 19. The medium according to claim 18 , which comprises at least one compound of each of the compounds of formulae II and III. 20. A process for the preparation of a liquid-crystalline medium according to claim 18 , comprising mixing together one or more compounds of formulae I-1 and I-2 with one or more compounds of each of formula II, III, IV and V.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10190048B2 cover?
The invention relates to a liquid-crystalline medium, preferably having a nematic phase and negative dielectric anisotropy, which comprises a) one or more compounds of formula I and b) one or more compounds selected from the group of compoun…
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/3098. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).